{
  "DOI": "10.1007/s10689-021-00278-6",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-021-00278-6",
  "alternative-id": [
    "278"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "25 August 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "28 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "8 October 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no conflict of interest. SMN, KEH, RT and EDE are all employees and shareholders of the Invitae Corporation."
    },
    {
      "group": {
        "label": "Ethical approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The Institutional Review Board of the Sheba Medical center approved the study."
    },
    {
      "group": {
        "label": "\u003c!--Emphasis Type='Bold' removed--\u003eConsent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "irrelevant."
    },
    {
      "group": {
        "label": "\u003c!--Emphasis Type='Bold' removed--\u003eConsent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 5,
      "value": "Irrelevant."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Laitman",
      "given": "Yael",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Nielsen",
      "given": "Sarah M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hatchell",
      "given": "Kathryn E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Truty",
      "given": "Rebecca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bernstein-Molho",
      "given": "Rinat",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Esplin",
      "given": "Edward D.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-6745-1733",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Friedman",
      "given": "Eitan",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        10,
        8
      ]
    ],
    "date-time": "2021-10-08T23:14:47Z",
    "timestamp": 1633734887000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        6,
        16
      ]
    ],
    "date-time": "2022-06-16T07:19:25Z",
    "timestamp": 1655363965000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        28
      ]
    ],
    "date-time": "2024-02-28T17:03:59Z",
    "timestamp": 1709139839926
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2021,
        10,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2022,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            8
          ]
        ],
        "date-time": "2021-10-08T00:00:00Z",
        "timestamp": 1633651200000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            8
          ]
        ],
        "date-time": "2021-10-08T00:00:00Z",
        "timestamp": 1633651200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00278-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-021-00278-6/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00278-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "305-308",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        10,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        10,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.2147/BCTT.S111394",
      "author": "P Apostolou",
      "doi-asserted-by": "publisher",
      "first-page": "331",
      "journal-title": "Breast Cancer (Dove Med Press)",
      "key": "278_CR1",
      "unstructured": "Apostolou P, Papasotiriou I (2017) Current perspectives on CHEK2 mutations in breast cancer. Breast Cancer (Dove Med Press) 9:331–335. https://doi.org/10.2147/BCTT.S111394",
      "volume": "9",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2016.66.5844",
      "author": "MK Schmidt",
      "doi-asserted-by": "publisher",
      "first-page": "2750",
      "issue": "23",
      "journal-title": "J Clin Oncol",
      "key": "278_CR2",
      "unstructured": "Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, van den Ouweland A, Hooning M, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Arndt V, Bermisheva M, Bogdanova NV, Bolla MK, Brauch H, Brenner H, Brüning T, Burwinkel B, Chang-Claude J, Chenevix-Trench G, Couch FJ, Cox A, Cross SS, Czene K, Dunning AM, Fasching PA, Figueroa J, Fletcher O, Flyger H, Galle E, García-Closas M, Giles GG, Haeberle L, Hall P, Hillemanns P, Hopper JL, Jakubowska A, John EM, Jones M, Khusnutdinova E, Knight JA, Kosma VM, Kristensen V, Lee A, Lindblom A, Lubinski J, Mannermaa A, Margolin S, Meindl A, Milne RL, Muranen TA, Newcomb PA, Offit K, Park-Simon TW, Peto J, Pharoah PD, Robson M, Rudolph A, Sawyer EJ, Schmutzler RK, Seynaeve C, Soens J, Southey MC, Spurdle AB, Surowy H, Swerdlow A, Tollenaar RA, Tomlinson I, Trentham-Dietz A, Vachon C, Wang Q, Whittemore AS, Ziogas A, van der Kolk L, Nevanlinna H, Dörk T, Bojesen S, Easton DF (2016) Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers. J Clin Oncol 34(23):2750–2760. https://doi.org/10.1200/JCO.2016.66.5844",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s40291-018-0344-x",
      "author": "M Liang",
      "doi-asserted-by": "publisher",
      "first-page": "397",
      "journal-title": "Mol Diagn Ther",
      "key": "278_CR3",
      "unstructured": "Liang M, Zhang Y, Sun C, Rizeq FK, Min M, Shi T, Sun Y (2004) Association between CHEK2*1100delC and breast cancer: a systematic review and meta-analysis. Mol Diagn Ther 22:397–407. https://doi.org/10.1007/s40291-018-0344-x",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1086/426403",
      "author": "C Cybulski",
      "doi-asserted-by": "publisher",
      "first-page": "1131",
      "journal-title": "Am J Hum Genet",
      "key": "278_CR4",
      "unstructured": "Cybulski C, Górski B, Huzarski T, Masojć B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymańska A, Szymańska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubiński J (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75:1131–1135. doi:https://doi.org/10.1086/426403",
      "volume": "75",
      "year": "2004"
    },
    {
      "DOI": "10.1136/gutjnl-2012-304121",
      "author": "X Ma",
      "doi-asserted-by": "publisher",
      "first-page": "326",
      "journal-title": "Gut",
      "key": "278_CR5",
      "unstructured": "Ma X, Zhang B, Zheng W (2013) Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Gut 63:326–336. doi:https://doi.org/10.1136/gutjnl-2012-304121",
      "volume": "63",
      "year": "2013"
    },
    {
      "DOI": "10.1002/pros.23505",
      "author": "Y Wu",
      "doi-asserted-by": "publisher",
      "first-page": "607",
      "journal-title": "Prostate",
      "key": "278_CR6",
      "unstructured": "Wu Y, Yu H, Zheng SL, Na R, Mamawala M, Landis T, Wiley K, Petkewicz J, Shah S, Shi Z, Novakovic K, McGuire M, Brendler CB, Ding Q, Helfand BT, Carter HB, Cooney KA, Isaacs WB, Xu J (2018) A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. Prostate 78:607–615. doi:https://doi.org/10.1002/pros.23505",
      "volume": "78",
      "year": "2018"
    },
    {
      "DOI": "10.1097/MPA.0000000000001136",
      "author": "W Zhan",
      "doi-asserted-by": "publisher",
      "first-page": "924",
      "journal-title": "Pancreas",
      "key": "278_CR7",
      "unstructured": "Zhan W, Shelton CA, Greer PJ, Brand RE, Whitcomb DC (2018) Germline variants and risk for pancreatic cancer: a systematic review and emerging concepts. Pancreas 47:924–936. https://doi.org/10.1097/MPA.0000000000001136",
      "volume": "47",
      "year": "2018"
    },
    {
      "DOI": "10.1093/hmg/ddi052",
      "author": "A Shaag",
      "doi-asserted-by": "publisher",
      "first-page": "555",
      "journal-title": "Hum Mol Genet",
      "key": "278_CR8",
      "unstructured": "Shaag A, Walsh T, Renbaum P, Kirchhoff T, Nafa K, Shiovitz S, Mandell JB, Welcsh P, Lee MK, Ellis N, Offit K, Levy-Lahad E, King MC (2005) Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet 14:555–563. doi:https://doi.org/10.1093/hmg/ddi052",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1001/jamaoncol.2017.1996",
      "author": "T Walsh",
      "doi-asserted-by": "publisher",
      "first-page": "1647",
      "journal-title": "JAMA Oncol",
      "key": "278_CR9",
      "unstructured": "Walsh T, Mandell JB, Norquist BM, Casadei S, Gulsuner S, Lee MK, King MC (2017) Genetic predisposition to breast cancer due to mutations other than BRCA1 and BRCA2 founder Alleles among Ashkenazi Jewish women. JAMA Oncol 3:1647–1653. https://doi.org/10.1001/jamaoncol.2017.1996",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.jmoldx.2015.04.009",
      "author": "SE Lincoln",
      "doi-asserted-by": "publisher",
      "first-page": "533",
      "journal-title": "J Mol Diagn",
      "key": "278_CR10",
      "unstructured": "Lincoln SE, Kobayashi Y, Anderson MJ, Yang S, Desmond AJ, Mills MA, Nilsen GB, Jacobs KB, Monzon FA, Kurian AW, Ford JM, Ellisen LW (2015) A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn 17:533–544. https://doi.org/10.1016/j.jmoldx.2015.04.009",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2017.37",
      "author": "Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M, Invitae Clinical Genomics Group, Topper S",
      "doi-asserted-by": "publisher",
      "first-page": "1105",
      "journal-title": "Genet Med",
      "key": "278_CR11",
      "unstructured": "Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M, Invitae Clinical Genomics Group, Topper S (2017) Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med 19:1105–1117. https://doi.org/10.1038/gim.2017.37 (Erratum in: Genet Med. 2020 Jan;22(1):240-242)",
      "volume": "19",
      "year": "2017"
    }
  ],
  "reference-count": 11,
  "references-count": 11,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-021-00278-6"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "21"
}